Login / Signup

Robot-assisted pancreatoduodenectomy with the da Vinci Xi: can the costs of advanced technology be offset by clinical advantages? A case-matched cost analysis versus open approach.

Gregorio Di FrancoValentina LorenzoniMatteo PalmeriNiccolò FurbettaSimone GuadagniDesirée GianardiMatteo BianchiniLuca Emanuele PollinaFranca MelfiDomenica MamoneCarlo MilliGiulio Di CandioGiuseppe TurchettiLuca Morelli
Published in: Surgical endoscopy (2021)
Robot-assisted surgery is more expensive because of higher acquisition and maintenance costs. However, although RPD is associated to higher material costs, the advantages of the robotic system associated to lower hospital stay costs and the absence of difference in terms of personnel costs thanks to the similar operative time with respect to OPD, make the OVCs of the two techniques no longer different. Hence, the higher costs of advanced technology can be partially compensated by clinical advantages, particularly within a high-volume multidisciplinary center for both robot-assisted and pancreatic surgery. These preliminary data need confirmation by further studies.
Keyphrases
  • robot assisted
  • minimally invasive
  • healthcare
  • coronary artery bypass
  • emergency department
  • machine learning
  • atrial fibrillation
  • surgical site infection
  • quality improvement
  • adverse drug